COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,800 Articles (22,527 medRxiv, 8,273 bioRxiv)

Most recent first Previous |  Page 868: Articles 8671-8680  | Next

Breakthrough SARS-CoV-2 infections in immune mediated disease patients undergoing B cell depleting therapy
Calabrese, C. M., Husni, E. M., Moss, B. M., Fernandez, A. J., Jin, Y., Kirchner, E., Calabrese, L. H.
10.1101/2022.02.21.22271289 — Posted: 2022-02-22
Psychological and financial impacts of COVID-19-related travel measures: An international cross-sectional study
McDermid, P., Sooppiyaragath, S., Craig, A., Sheel, M., Blazek, K., Talty, S., Seale, H.
10.1101/2022.02.21.22271299 — Posted: 2022-02-22
The efficacy, effectiveness and safety of SARS-CoV-2 disinfection methods (including ozone machines) in educational settings for children and young people
Edwards, D., Csontos, J. K., Gillen, E., Lewis, R., Cooper, A., Gal, M., Law, R.-J., Edwards, A.
10.1101/2022.02.21.22271281 — Posted: 2022-02-22
An inactivated SARS-CoV-2 vaccine is safe and induces humoral and cellular immunity against virus variants in healthy children and adolescents in Chile
Soto, J. A., Melo-Gonzalez, F., Gutierrez-Vera, C., Schultz, B. M., Berrios-Rojas, R. V., Rivera-Perez, D., Pina-Iturbe, A., Hoppe-Elsholz, G., Duarte, L. F., Vazquez, Y., Moreno-Tapia, D., Rios, M., Palacios, P. A., Garcia-Betancourt, R., Santibanez, A., Mendez, C., Diethelm-Varela, B., Astudillo, P., Calvo, M., Cardenas, A., Gonzalez, M., Goldsack, M., Gutierrez, V., Potin, M., Schilling, A., Tapia, L. I., Twele, L., Villena, R., Grifoni, A., Sette, A., Weiskopf, D., Fasce, R. A., Fernandez, J., Mora, J., Ramirez, E., Gaete-Argel, A., Acevedo, M., Valiente-Echeverria, F., Soto-Rifo, R., Retamal-Diaz, A., Munoz-Jofre, N., PedCoronaVac03CL Study Group, , Meng, X., Xin, Q., Alarcon-Bustamante, E., Gonzalez-Aramundiz, J. V., Le Corre, N., Javiera Alvarez, M., Gonzalez, P. A., Abarca, K., Perret, C., Carreno, L. J., Bueno, S. M., Kalergis, A. M.
10.1101/2022.02.15.22270973 — Posted: 2022-02-22
A role for Nucleocapsid-specific antibody function in Covid-19 Convalescent plasma therapy
Herman, J. D., Wang, C., Burke, J. S., Zur, Y., Compere, H., Kang, J., Macvicar, R., Shin, S., Frank, I., Siegel, D., Tebas, P., Choi, G. H., Shaw, P. A., Yoon, H., Pirofski, L.-a., Juelg, B., Bar, K. J., Lauffenburger, D., Alter, G.
10.1101/2022.02.19.22271230 — Posted: 2022-02-22
Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care setting
Rane, M. S., Robertson, M., Kulkarni, S., Frogel, D., Gainus, C., Nash, D.
10.1101/2022.02.21.22271298 — Posted: 2022-02-22
Childhood Trauma Exposure Increases Long COVID Risk
Villanueva van den Hurk, A. W., Ujvari, C., Greenspan, N., Malaspina, D., Jimenez, X. F., Walsh-Messinger, J.
10.1101/2022.02.18.22271191 — Posted: 2022-02-22
Tackling the first COVID-19 wave at the Cape Town Hospital of Hope: Why was it such a positive experience for staff?
Reid, S., Nana, M., Abrahams, T., Von Pressentin, K., Okun, R., Ras, T., Hussey, N.
10.1101/2022.02.21.22271306 — Posted: 2022-02-22
Community-based Case Studies of Vaccine Hesitancy and the COVID-19 Response in South Africa; The VaxScenes Study
Wiysonge, C. S., Coulson, N., Pillay, N., Cooper, S., Groenewald, C., Essack, Z., Parker, S., Houston, G., Simmonds, J., Jaca, A., Mutemwa, M., Katoto, P. D., Rooyen, H. v.
10.1101/2022.02.21.22271272 — Posted: 2022-02-22
Using Best-Worst Scaling to investigate younger adult Canadians' preferences for COVID-19 vaccination and public health measures: an observational study
Tatar, O., Haward, B., Zhu, P., Griffin-Mathieu, G., Perez, S., Zimet, G., Rosberger, Z.
10.1101/2022.02.18.22271180 — Posted: 2022-02-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).